Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
Henry Gómez(National Cancer Center), Carlos Vallejos, Jorge Otero, Daniel Lee Kay Pen, Carlos Carracedo, Manuel Hidalgo(Hospital Universitario de Fuenlabrada), L. Casanova, W. Rodríguez, H. Cortés-Funes(Centre Hospitalier René-Dubos), Rámón Colomer(Hospital Universitario de La Princesa)
Cited by 169
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k